Substances · Cannabinoids (Indazole carboxamides)
4F-MDMB-BINACA
- Preferred name
- 4F-MDMB-BINACA
- IUPAC name
- methyl (2S)-2-[[1-(4-fluorobutyl)indazole-3-carbonyl]amino]-3,3-dimethylbutanoate
- Parent CAS number (reference)
- 2390036-46-9
- Molecular formula
- C19H26FN3O3
- Molecular weight
- 363.4 g/mol
- InChIKey
- GZGKSDAMWRWYOZ-MRXNPFEDSA-N
- PubChem
- CID 145707216
- Source
- PubChem
- Verified synonyms & catalog abbreviations
-
4F-MDMB-BUTINACA 4-Fluoro-MDMB-BINACA 4F-ADB 4FMDMBBINACA 4F MDMB BINACA
Verified Neurochemical & Toxicological Intelligence
4F-MDMB-BINACA (4F-MDMB-BUTINACA)
Receptor Telemetry & Mechanism of Action
Potent indazole-3-carboxamide CB1 agonist shortening 5F-MDMB-PINACA's 5-fluoropentyl tail by one carbon to a 4-fluorobutyl chain (C19H26FN3O3 — distinct from pentyl isomer 4F-MDMB-PINACA and indole 4F-MDMB-BICA). In WHO 42nd ECDD GTPgammaS assays, 4F-MDMB-BINACA activated human CB1 at EC50 = 0.20 nM (Emax = 67.7% vs. CP-55,940; ~71-fold more potent than Delta9-THC at EC50 = 14.2 nM), while beta-arrestin assays report EC50 = 5.69–7.39 nM. Repeated oral administration in rats also induced considerable liver, kidney, and metabolic toxicity.
Biotransformation & Active Metabolites
Biotransformed via methyl ester cleavage, hydrolytic defluorination, oxidation to a butanoic acid metabolite, N-dealkylation, dehydrogenation, and aromatic/alkyl hydroxylation.
Temporal Pharmacokinetics
Fast-hitting, heavy cannabimimetic sedation, perceptual warping, and mood elevation at low microgram levels, escalating sharply into confusion, ataxia, tachycardia, vomiting, and stupor if over-titrated.
- Onset 1–3 minutes inhaled
- Peak Window 10–30 minutes inhaled
- Total Window 1–2.5 hours inhaled (class estimate; WHO 42nd ECDD notes exact human duration is unestablished)
- Residual / Half-Life 1–4 hours of residual somnolence and cognitive fog; human plasma half-life is unverified.
MICROGRAM POTENCY HAZARD: Roughly ~4-fold higher in beta-arrestin EC50 than 5F-MDMB-PINACA yet still ~71 times more potent than THC in GTPgammaS binding and prominently identified in post-mortem forensic casework. Active exposures sit in the estimated 60–250 ug range; unweighed 1 mg powder grains risk abrupt unconsciousness, seizures, and fatal toxicity.
Quantitative Response Spectrum (Published Literature)
Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.
30–60 ug (0.03–0.06 mg — tentative microgram estimate)
Subtle sensory softening, mild mood lift, and early relaxation.
Slight ocular warmth and faint dry mouth.
60–120 ug (0.06–0.12 mg — tentative microgram estimate)
Calm cannabimimetic mood elevation, brightened music/sensory perception, and slowed thought pace.
Dry mouth, red eyes, gentle muscle heaviness, and mild pulse increase.
120–250 ug (0.12–0.25 mg — tentative microgram estimate)
Pronounced heavy stone, time dilation, short-term memory impairment, and dreamy detachment.
Marked sedation, impaired motor coordination, tachycardia, dizziness, and appetite stimulation.
250–400 ug (0.25–0.40 mg — tentative microgram estimate)
Severe confusion, dissociative vertigo, acute anxiety/paranoia, and memory blackouts.
Strong ataxia, orthostatic hypotension, nausea/emesis, tremors, and palpitations.
400–500+ ug (0.40–0.50+ mg — tentative microgram estimate)
Coma / sudden loss of consciousness, agitated delirium, and acute psychosis.
Severe vomiting with aspiration risk, convulsions, respiratory depression, hepatorenal stress, and fatal intoxication.
Interaction Matrix & Critical Contraindications
Critical Hazard — Never Combine
Synergistic CNS depression, loss of gag reflex during vomiting, and fatal respiratory arrest.
Compounds CB1 overactivation; 69% of a 29-case US forensic series involving 4F-MDMB-BINACA originated from post-mortem investigations.
Precipitates severe tachycardia, arrhythmias, psychotic delirium, and convulsions.
Elevated Hazard — Avoid
Heightens seizure risk, severe confusion, and terrifying panic states.
Preclinical rat studies demonstrate considerable toxic effects on liver, kidney, and metabolic functions after 1-week oral exposure.
Caution / Receptor Attenuation
Never mix onto plant material—eliminates THC's partial-agonist safety margin.
Structural Isomer & Sibling Comparison
4F-MDMB-BINACA (4-fluorobutyl tail, C19H26FN3O3) is one methylene unit shorter than 5F-MDMB-PINACA (5-fluoropentyl tail, C20H28FN3O3). That 1-carbon shortening lowers beta-arrestin recruitment potency ~4-fold (EC50 5.69–7.39 nM vs. 0.84–1.78 nM for 5F-ADB), aligning 4F-MDMB-BINACA closely with MDMB-4en-PINACA and ADB-BUTINACA while remaining ~71x more potent than botanical THC in GTPgammaS assays.
Physicochemical Stability & Storage
Physical Form: White or off-white neat solid or crystalline powder (NEVER supplied on sprayed herbs). · Soluble in DMF, ethanol, dichloromethane, and methanol; partially soluble in water.
Store sealed, dry, and protected from light at -20 °C or cool room temperature.
Cross-Tolerance & Dependence Profile
Rapid CB1 receptor tolerance and physical dependence with repeated use; full cross-tolerance across all synthetic and botanical cannabinoids.
Codes on this card
Short meanings for the abbreviations printed with this substance.
CB₁ / CB₂
Cannabinoid receptors CB1 and CB2
CB1 and CB2 are the two cannabinoid receptors named on these cards. Papers usually discuss CB1 in the nervous system and CB2 more often in immune tissue. The number beside them is often a Ki in nanomoles.
EC₅₀ / IC₅₀
Halfway concentration
EC50 is the concentration where a lab saw half of the maximum measured effect. IC50 is the concentration where it saw half of the maximum block. Smaller means that halfway point came at a lower concentration.
Kᵢ
Binding tightness in nanomoles
Ki says how tightly a compound sits on a receptor in a binding test. It is written in nanomoles per litre. A Ki of 1 nM means very tight binding in that experiment.
ratio
Selectivity ratio
A selectivity ratio divides two halfway numbers, such as SERT EC50 by DAT EC50, to show which target the assay reached first. The direction of the division has to be stated, or the number flips.
curve
Concentration-response curve
The response curve plots concentration along the bottom and the measured laboratory response up the side. It is usually flat, then steep, then flat again near the top. EC50 sits on the steep middle.
CAS
CAS registry number
A CAS number is a passport number for one chemical entry in the CAS registry. The free base and a salt of the same parent usually have different CAS numbers.
IUPAC
IUPAC Name & Molecular Formula
The molecular formula counts how many atoms of each element sit in one molecule, while the IUPAC name is the systematic map showing exactly how those atoms are connected.
CID / InChIKey
PubChem CID & Standard InChIKey
PubChem CID is the catalog number in the U.S. National Library of Medicine chemistry database, and InChIKey is a 27-character digital fingerprint of the molecule's exact 3D structure.
Chemical Architecture & Structural Profile
4F-MDMB-BINACA (methyl (2S)-2-[[1-(4-fluorobutyl)indazole-3-carbonyl]amino]-3,3-dimethylbutanoate) is a reference compound belonging to the Cannabinoids (Indazole carboxamides) class, characterized by the molecular formula C19H26FN3O3 and a molar mass of 363.4 g/mol. The parent molecule is indexed under CAS registry number 2390036-46-9 and in the NCBI PubChem database as CID 145707216 (Standard InChIKey: GZGKSDAMWRWYOZ-MRXNPFEDSA-N).
Citations
- PubChem — PubChem (2026-11-12)
Reference Toxicology & Safety Profile
In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), 4F-MDMB-BINACA is indexed within the Cannabinoids (Indazole carboxamides) structural group. Synthetic indazole carboxamide exhibiting high receptor affinity in in-vitro assays; requires calibrated micro-analytical balances and full dermal and respiratory protection. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.
Citations
- PubChem — PubChem (2026-11-12)
Analytical Use & Laboratory Notice
This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.
Citations
- Riksdagen — Förordning (1999:58) om förbud mot vissa hälsofarliga varor — Sveriges riksdag (2026-11-12)